This fund will be available to support solutions that are aligned with national health priorities, such as oxygen delivery systems, cold chain storage for vaccines, supply chain management for pharmaceuticals, training for healthcare workers, and other facility and community-based interventions, and can be rapidly scaled to address COVID-19 and subsequent health crisis.
SAMRIDH works in technical collaboration with premier institutions, such as the Indian Institute of Technology-Delhi, the Principal Scientific Advisor to the Government of India, the National Health Authority, and NATHEALTH, mobilizing financial assistance to healthcare enterprises and innovators to support scaling up of market-based health solutions.
SAMRIDH is led and implemented by a Technical Support Unit, managed by IPE Global.
On receiving this huge funding for SAMRIDH, Ashwajit Singh, Managing Director, IPE Global said, “We welcome USAID’s additional support to SAMRIDH at this juncture, when healthcare systems in India need urgent reinforcements, to respond to the rapidly emerging implications of COVID-19. This assistance will enable us to support scale-up and deployment of live saving health solutions. With our continued engagement with USAID, we envision to build resilient and inclusive health systems in India, ensuring access to timely, affordable and quality healthcare services for all”.